Quest Diagnostics Incorporated (DGX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Quest Diagnostics Incorporated, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 19.42x | 19.23x | 18.08x | 19.18x | 10.84x | 11.16x |
| P/B Ratio | 2.69x | 2.47x | 2.45x | 3.08x | 3.36x | 2.36x |
| P/S Ratio | 1.75x | 1.70x | 1.67x | 1.84x | 2.00x | 1.69x |
| Profitability | ||||||
| Gross Margin | 31.9% | 32.9% | 33.2% | 34.7% | 39.0% | 38.5% |
| Operating Margin | 14.5% | 13.6% | 13.6% | 14.4% | 22.1% | 20.9% |
| Net Margin | 9.0% | 8.8% | 9.2% | 9.6% | 18.5% | 15.2% |
| EBITDA Margin | 19.9% | 19.2% | 18.7% | 18.4% | 29.3% | 25.5% |
| Liquidity | ||||||
| Current Ratio | 1.04x | 1.10x | 1.31x | 1.22x | 1.56x | 1.72x |
| Quick Ratio | 0.96x | 1.02x | 1.20x | 1.10x | 1.44x | 1.60x |
| Leverage | ||||||
| Debt/Equity | 0.96x | 1.05x | 0.87x | 0.80x | 0.74x | 0.71x |
YoY = year-over-year change. Source: FMP..